SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics…
Company Intends to Continue Operations Without Interruption While Reducing Debt and Strengthening Balance Sheet GALLIANO, La., March 25, 2026 /PRNewswire/…